Skip to main content

Bone Marrow Transplant clinical trials at UC Cancer

1 research study open to eligible people

Showing trials for
  • Haploidentical Bone Marrow Transplantation in Sickle Cell Patients (BMT CTN 1507)

    open to eligible people ages 5-45

    This is a Phase II, single arm, multi-center trial, designed to estimate the efficacy and toxicity of haploidentical bone marrow transplantation (BMT) in patients with sickle cell disease (SCD). Based on their age and entry criteria patients are stratified into two groups: (1) children with SCD with strokes; and (2) adults with severe SCD.

    at UCSF

Last updated: